Medical Probiotics Market Size is valued at USD 39.32 Bn in 2022 and is predicted to reach USD 64.13 Bn by the year 2031 at a 5.76% CAGR during the forecast period for 2023-2031.
Probiotics are "live microorganisms" that can improve health in various ways. They are beneficial to digestion because they promote gut health. To get your probiotics, try some yoghurt. The market for probiotics is growing due to rising health consciousness among consumers, increased knowledge about the benefits of probiotics, an ageing population, and the prevalence of digestive problems. Increases in meat consumption in developing countries also drive growth in the feed probiotics industry. Besides aiding digestion, probiotics have numerous additional health benefits, including improving immunity, maintaining gut health, managing weight, lowering obesity, and many more. More and more people are realizing the advantages should drive demand higher. As health concerns continue to gain prominence and as the vegan movement expands, demand for plant-based products is expected to increase. Furthermore, more and more supplements targeting inflammatory skin conditions like eczema and atopic dermatitis are being made with the help of probiotics. The expansion of the probiotics industry can be attributed to all of these factors.
However, the market growth is hampered by the strict regulatory criteria for the safety and health of the medical probiotics market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high humidity medical probiotics because probiotics are living bacteria their cultivation and secretion are essential to the production of any product containing probiotics. Production of a given batch is likely to be hampered by the possibility of contamination from microorganisms that aren't wanted and have a high toxicity level. Additionally, the significant expenditure needed for bacterial strain research and development is anticipated to restrict market expansion further. As a result of COVID-19's unexpected impact, there has been a rise in the demand for products that boost immune health, which is good news for the probiotics industry. Many new products are being introduced because of these causes to keep up with the rising demand.
The medical probiotics market is segmented based on ingredient type, application and distribution channel. As per the ingredient type, the market is segmented into bacteria, yeast, spore formers, and others. The bacteria segment is again sub-divided into lactobacilli, Bifidobacterium, streptococcus and bacillus. By application, the market is segmented into probiotic food & beverages, probiotic dietary supplements, probiotics for women's health, infant formula, and others. The food and beverages segment includes dairy products, non-dairy beverages, cereals, baked goods and fermented meat products. The distribution channel segment is segmented into hypermarkets/supermarkets, pharmacies/drugstores, speciality stores, and online sales.
The yeast medical probiotics market is expected to lead with a major global market share in 2022. The yeast used in making probiotic beverages is Saccharomyces boulardii. It aids in maintaining normal intestinal function and ward off microorganisms that can cause injury to the intestinal lining. It maintains a healthy intestinal barrier and modulates additional immune system components. The increased awareness regarding the benefits linked with the intake of these items is predicted to push product sales positively.
The food & beverages industry makes up the bulk of medical probiotics because some foods and drinks have entered the mainstream diet. After all, evidence suggests they provide health benefits beyond those often attributed to their nutritional content. One of the most popular eating trends of the present is the regular use of functional foods and drinks. Natural and healthful food items are becoming more mainstream, boosting sales, especially in countries like the US, Germany, the U.K., China, and India.
The North American medical probiotics market is expected to register the maximum market share in revenue in the near future. It can be attributed to the growing interest in preventative medicine, the continued prevalence of lifestyle-related diseases, including obesity and diabetes, and the introduction of probiotic functional foods. In addition, Asia Pacific is estimated to grow rapidly in the global medical probiotics market because of the rising popularity of probiotic-containing foods and medicines.
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 39.32 Bn |
|
Revenue Forecast In 2031 |
USD 64.13 Bn |
|
Growth Rate CAGR |
CAGR of 5.76% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Ingredient Type, By Application, By Distribution Channel |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Probi AB, Abbott, Lonza, Chr. Hansen Holding A/S, Danone S.A., Yakult Honsha Co., Ltd., Nestle S.A., DowDuPont Inc., Kerry Group plc., BioGaia AB, DSM, Sun Genomics, Evonik, Probiotics International Limited (Protexin), UAS Laboratories LLC., Lallemand, Glac Biotech, Ab-Biotics, Winclove Probiotics, Sacco System, General Mills Inc., ADM, Unique Biotech Ltd, Lifeway Foods, Inc., Suja Life, Llc, Biohm Health, Others |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Medical Probiotics Market Snapshot
Chapter 4. Global Medical Probiotics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Ingredient Type Estimates & Trend Analysis
5.1. By Ingredient Type, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Ingredient Type:
5.2.1. Bacteria
5.2.1.1. Lactobacilli
5.2.1.2. Bifidobacterium
5.2.1.3. Streptococcus
5.2.1.4. Bacillus
5.2.2. Yeast
5.2.3. Spore Formers
5.2.4. Others
Chapter 6. Market Segmentation 2: By Distribution Channel Estimates & Trend Analysis
6.1. By Distribution Channel & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Distribution Channel:
6.2.1. Hypermarkets/Supermarkets
6.2.2. Pharmacies/Drugstores
6.2.3. Specialty Stores
6.2.4. Online Sales
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Application:
7.2.1. Probiotic Food & Beverages
7.2.1.1. Dairy Products
7.2.1.2. Non-dairy Beverages
7.2.1.3. Cereals
7.2.1.4. Baked Goods
7.2.1.5. Fermented Meat Products
7.2.2. Probiotic Dietary Supplements
7.2.3. Probiotics for Women’s Health
7.2.4. Infant Formula
7.2.5. Others
Chapter 8. Medical Probiotics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Medical Probiotics Market revenue (US$ Million) estimates and forecasts By Ingredient Type, 2019-2031
8.1.2. North America Medical Probiotics Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2019-2031
8.1.3. North America Medical Probiotics Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031
8.1.4. North America Medical Probiotics Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Medical Probiotics Market revenue (US$ Million) By Ingredient Type, 2019-2031
8.2.2. Europe Medical Probiotics Market revenue (US$ Million) By Distribution Channel, 2019-2031
8.2.3. Europe Medical Probiotics Market revenue (US$ Million) By Application, 2019-2031
8.2.4. Europe Medical Probiotics Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Medical Probiotics Market revenue (US$ Million) By Ingredient Type, 2019-2031
8.3.2. Asia Pacific Medical Probiotics Market revenue (US$ Million) By Distribution Channel, 2019-2031
8.3.3. Asia Pacific Medical Probiotics Market revenue (US$ Million) By Application, 2019-2031
8.3.4. Asia Pacific Medical Probiotics Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Medical Probiotics Market revenue (US$ Million) By Ingredient Type, (US$ Million) 2019-2031
8.4.2. Latin America Medical Probiotics Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031
8.4.3. Latin America Medical Probiotics Market revenue (US$ Million) By Application, (US$ Million) 2019-2031
8.4.4. Latin America Medical Probiotics Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Medical Probiotics Market revenue (US$ Million) By Ingredient Type, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Medical Probiotics Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Medical Probiotics Market revenue (US$ Million) By Application, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Medical Probiotics Market revenue (US$ Million) by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Probi AB,
9.2.2. Abbott,
9.2.3. Lonza, Chr.
9.2.4. Hansen Holding A/S,
9.2.5. Danone S.A.,
9.2.6. Yakult Honsha Co., Ltd.,
9.2.7. Nestle S.A.,
9.2.8. DowDuPont Inc.,
9.2.9. Kerry Group plc.,
9.2.10. BioGaia AB, DSM,
9.2.11. Sun Genomics,
9.2.12. Evonik,
9.2.13. Probiotics International Limited (Protexin),
9.2.14. UAS Laboratories LLC,.
Medical Probiotics Market By Ingredient Type
Medical Probiotics Market By Application
Medical Probiotics Market By Distribution Channel
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
